Graft vs Host Disease
A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD) (EFC17757)
- Details
ClinicalTrials.gov ID:
NCT06143891
Diagnosis Type:
NA
USOR Number:
- Address
,
P: